MedTrace Logo

Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)

NCT05095792 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-11-14

No results posted yet for this study

Summary

This observational study will allow data to be collected to demonstrate changes in brain activity following administration of standard of care (SOC) Ketamine. By comparing genetic markers across participants, data on impact of genetic markers and response to Ketamine will also be analysed. This data will contribute to the design of future studies utilizing Ketamine for various psychiatric disorders. This study will focus on treatment-resistant Major Depressive Disorder (MDD).

Conditions

  • Treatment-resistant Depression

Interventions

OTHER

Observational - no intervention

This is an observational study with no intervention.

Sponsors & Collaborators

  • Entheon Biomedical Corp.

    lead INDUSTRY

Principal Investigators

  • Steven Levine, MD · Heading Health

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-09
Primary Completion
2022-10-21
Completion
2022-10-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05095792 on ClinicalTrials.gov